Clinical Trials Browser

Interventional × tandutinib × Genitourinary × Clear all

NCT00408902 2017-11-22

Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer

Phase 2 Completed

10 enrolled 6 charts

Carcinoma, Renal Cell

NCT00390468 2014-05-28

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Phase 2 Completed

18 enrolled 5 charts

Neoplasm Metastasis, Pain, Prostatic Neoplasms